Riskpilot← Back to searchSign inGet full accessStellafarma Oy
OYDissolvedY-tunnus 2377255-6Isonniitynpolku 16Retail sale of other food · NACE 4727Est. 2010— employees
Revenue 2024
EUR 19K
+35% vs 2023
EBITDA margin
2.3%
-64% vs 2023
Equity ratio
80.7%
Financial strength
Net profit 2024
EUR 8K
+165% vs 2023
| Revenue | EUR 19K | +35% |
| EBITDA | EUR 445 | -64% |
| Net profit | EUR 8K | +165% |
| Total assets | EUR 1,5M | -10% |
| Equity | EUR 1,2M | -7% |
| Employees | — | — |
Legal name
Stellafarma Oy
Y-tunnus number
2377255-6
Legal form
Osakeyhtiö
NACE code
4727 · Retail sale of other food
Founded
13. joulukuuta 2010
Share capital
EUR 5 000
Employees
—
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Hallituksen jäsen, toimitusjohtaja ja toimitusjohtajan sijainen kukin yksin
Company purpose
Yhtiön toimiala on luontaistuotteiden ja muiden hyvinvointiin liittyvien tuotteiden ja palveluiden myynti sekä kaikki muu laillinen ja hyvän tavan mukainen toiminta.
Address
Isonniitynpolku 16
Phone
+358092766950
Email
marja-leena.ikalainen@apteekit.net
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 1 526 | 11 | 9 | 14 | 19 |
| Staff expenses | −7 | −0 | — | −0 | −0 |
| EBITDA | 474 | 1 | −18 | 1 | 0 |
| Depreciation & amort. | −7 | −1 | — | −0 | −0 |
| EBIT | 467 | 1 | −18 | 1 | 0 |
| Net financials | 37 | −2 | 13 | −14 | 8 |
| Profit before tax | 505 | −1 | −5 | −13 | 8 |
| Tax | 101 | −0 | −0 | −0 | −0 |
| Net profit | 404 | −1 | −5 | −13 | 8 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 1 938 | 1 615 | 1 733 | 1 695 | 1 520 |
| Equity | 1 724 | 1 586 | 1 454 | 1 325 | 1 227 |
| Long-term debt | — | — | 170 | 170 | 0 |
| Short-term debt | 213 | 29 | 109 | 201 | 293 |
| Total debt | 213 | 29 | 279 | 371 | 293 |
EBITDA margin
2.3%
This company
15.8%
Market median
-85% vs market
20202024
Equity ratio
80.7%
This company
38.2%
Market median
+111% vs market
20202024
Return on equity
0.7%
This company
18.4%
Market median
-96% vs market
20202024
Net profit margin
43.0%
This company
8.1%
Market median
+431% vs market
20202024
Asset turnover
0.01×
This company
1.12×
Market median
-99% vs market
20202024
Debt / equity
0.24×
This company
0.62×
Market median
+61% vs market
20202024
- Annual report 2024Filed via PRH / YTJ · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via PRH / YTJ · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via PRH / YTJ · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via PRH / YTJ · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via PRH / YTJ · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (3) | ||
CR | Audit | 2016 |
EV Deputy Member | Deputy Member | 2016 |
JF Deputy auditor | Deputy auditor | 2016 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Chairperson | 2016 | |
| Board of Directors | 2016 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of Stellafarma Oy also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Christian Richard Räihä | Audit | 0 companies |
| Elina Vappu Kanerva Mattila | Deputy Member | 0 companies |
| Johan-Erik Fant | Deputy auditor | 0 companies |
| Marja-Leena Hannele Ikäläinen | Chairperson | 0 companies |
| Tuomo Harri Sakari Ikäläinen | Board of Directors | 0 companies |